Our study reveals that the co-expression frequencies of PD-1/4-1BB, PD-1/ICOS, and PD-1/CD28 on CD8+TILs (capable of specifically recognizing and killing tumor cells) from cervical cancer are higher than those in PBMCs. This evidence concerns the gene CD28 and cervical cancer.